Bioengineering Methods in MicroRNA-Mediated Direct Reprogramming of Fibroblasts Into Cardiomyocytes

Ischemic heart disease is the major cause of mortality worldwide. Despite the most recent pharmacological progresses, cardiac regeneration is yet not possible, and heart transplantation is the only therapeutic option for end-stage heart failure. Traditional cardiac regenerative medicine approaches,...

Descripción completa

Detalles Bibliográficos
Autores principales: Paoletti, Camilla, Chiono, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573325/
https://www.ncbi.nlm.nih.gov/pubmed/34760946
http://dx.doi.org/10.3389/fcvm.2021.750438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573325/
https://www.ncbi.nlm.nih.gov/pubmed/34760946
http://dx.doi.org/10.3389/fcvm.2021.750438

Ejemplares similares